F. Turnbull

Cardiology and Cardiovascular Medicine · 2003–2021

A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Cardiology and Cardiovascular Medicine — 64 citations into it; #584 of 906 by trust here, #95 by citations
• Endocrinology, Diabetes and Metabolism — 20 citations into it

Whom F. Turnbull trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Barry R. Davis
2. G. Bakris

Who trusts F. Turnbull overall

1. N. Wong
2. Sebastian Schneeweiss
3. M. Law
4. V. Basevi

Papers from F. Turnbull's perspective

Ordered by how strongly the researchers F. Turnbull trusts endorse each paper. Same corpus, a different order for every researcher.

1. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (Journal of the American Medical Association (JAMA))
2. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. (Diabetes Care)
3. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study (British medical journal)
4. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. (Diabetes Care)
5. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. (Kidney International)
6. Long-term follow-up after tight control of blood pressure in type 2 diabetes. (New England Journal of Medicine)
7. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies (British medical journal)
8. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. (The Lancet)
9. Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? (Annals of Internal Medicine)
10. Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease (New England Journal of Medicine)

Their papers

• Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) — 619 citations
• Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. (2016) — 970 citations
• Intensive glucose control and macrovascular outcomes in type 2 diabetes (2009) — 1,096 citations
• Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials (2008) — 708 citations
• Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials (2005) — 786 citations
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. (2003) — 2,436 citations